B-type natruiretic peptide levels stratify the risk for arrhythmia among implantable cardioverter defibrillator patients.

@article{Galante2008BtypeNP,
  title={B-type natruiretic peptide levels stratify the risk for arrhythmia among implantable cardioverter defibrillator patients.},
  author={O. L. Galante and Guy Amit and Doron Zahger and Abraham Wagshal and Reuben Ilia and Amos Katz},
  journal={Clinical cardiology},
  year={2008},
  volume={31 12},
  pages={
          586-9
        }
}
BACKGROUND We sought to study the association between brain natriuretic peptide (BNP) levels and the occurrence of ventricular arrhythmias in patients with left ventricular dysfunction (LVD) and an implantable cardioverter defibrillator (ICD). METHODS This was a prospective study of consecutive, stable, ambulatory patients with moderate and severe ischemic LVD and an ICD. A plasma BNP level was obtained at recruitment. Patients were evaluated every 3-6 mo for a minimum of 1 y. The primary end… CONTINUE READING
Highly Cited
This paper has 23 citations. REVIEW CITATIONS

Citations

Publications citing this paper.
Showing 1-10 of 10 extracted citations

Relationship between cardiac autonomic function and sustained ventricular tachyarrhythmias in patients with an implantable cardioverter defibrillators.

Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology • 2010
View 3 Excerpts